Royal DSM, the global Life Sciences and Materials Sciences company, announced that it has reached agreement with Cargill to acquire Cargill's cultures and enzymes business in an all cash transaction for a total enterprise value of €85 million.
The transaction is expected to close in the next couple of months. DSM and Cargill announced on 20 September 2012 they were in exclusive discussions about this transaction.
The cultures and enzymes business of Cargill is a leading global manufacturer of cultures and enzymes for the dairy and meat industries with manufacturing operations in Wisconsin (USA) and France. The business generates net sales of about €45 million per year and has approximately 200 employees.
By combining the cultures and enzymes business of Cargill with the dairy business of DSM Food Specialties a strong global player will be created, enabling DSM to propel sales growth as well as capture sizable synergies in global manufacturing and customer reach as well as innovation capabilities in biotechnology and SG&A.
The combination of the two businesses will allow DSM to achieve its ambition to become a tier one supplier of cultures and enzymes to the global dairy market and will greatly accelerate DSM's growth plans for its business. The acquisition further strengthens DSM's global position in dairy ingredients with enzymes, PUFAs, vitamins, cultures, probiotics, bio actives, preservation systems and tests.
Stephan Tanda, Member of the DSM Managing Board and responsible for the Nutrition cluster, said: "This is a very important growth enhancing acquisition for our Food Specialties business and fully fits our strategy as we continue to create value for all stakeholders by providing innovative, sustainable solutions to the world's greatest current and future challenges".
Hans-Christian Ambjerg, President DSM Food Specialties, commented "We are very excited about this opportunity to build critical mass and to serve our customers faster. We look forward to welcoming the Cargill employees with their great knowledge and expertise."
The acquisition of Cargill's cultures and enzymes business is the eighth acquisition in the Nutrition cluster since DSM announced its corporate strategy DSM in motion.
To comment, login here
Or register to be able to comment.